Importantly, THOR status allows the differentiation of malignant tumor from normal tissue from the earliest stage of disease (P < 0.0001, Fig. 2C), suggesting that THOR methylation is an early event in BC carcinogenesis. Here, THORLNC is linked to breast cancer.